Loading...
Loading...
Toggle sidebar
Search Ctrl + K
Filing information
Xeris Biopharma Holdings, Inc.
Filing: 10-K
Filed On: 2024-03-06
Email Link to Filing
Print Filing
Download PDF
Download all tables
Your filing highlights
Compare documents
EDGAR Index Page
Documents
10-K
10-K
EX-10.39
exhibit1039redacted-amen.htm
EX-21.1
Subsidiaries of the registrant
EX-23.1
Consents of experts and counsel
EX-23.2
a202310-kexhibit232.htm
EX-31.1
Management Certification of annual or quarter disclosure
EX-31.2
Management Certification of annual or quarter disclosure
EX-32.1
Section 1350 Certifications
EX-32.2
a202310-kexhibit322.htm
EX-97.1
exhibit971final-xerisxco.htm
GRAPHIC
exhibit1039redacted-amen001.jpg
GRAPHIC
exhibit1039redacted-amen002.jpg
GRAPHIC
exhibit1039redacted-amen003.jpg
GRAPHIC
exhibit1039redacted-amen004.jpg
GRAPHIC
exhibit1039redacted-amen005.jpg
GRAPHIC
exhibit971final-xerisxco001.jpg
GRAPHIC
exhibit971final-xerisxco002.jpg
GRAPHIC
exhibit971final-xerisxco003.jpg
GRAPHIC
exhibit971final-xerisxco004.jpg
GRAPHIC
exhibit971final-xerisxco005.jpg
GRAPHIC
xers-20231231_g1.jpg
GRAPHIC
xers-20231231_g2.jpg
0001867096-24-000031.txt
Data files
EX-101.SCH
xers-20231231.xsd
EX-101.CAL
xers-20231231_cal.xml
EX-101.DEF
xers-20231231_def.xml
EX-101.LAB
xers-20231231_lab.xml
EX-101.PRE
xers-20231231_pre.xml
XML
xers-20231231_htm.xml
Free Trial
Save highlight
Link to highlight
Your browser does not support iframes.